The overall treatment effect of today’s medicine for skeletal tumors is relatively poor and can be controlled, but not eradicated. The treatment effect and prognosis of skeletal tumors are mainly determined by the type of tumor, and are also related to professional treatment techniques, nursing measures, personal living environment and other factors. Most of the malignant tumors have already metastasized and spread by the time they are detected because of their rapid growth and infiltrative or exophytic growth, so surgery cannot completely remove the tumors yet. At the same time, there are no special therapeutic drugs, so although radiotherapy and chemotherapy can be carried out, they can only slow down the growth of tumor to a certain extent, but cannot control the final result of its growth and metastasis. Most patients die due to tumor recurrence and metastasis and spread. Benign tumors have clear boundary with surrounding tissues and often have envelope, slow growth rate, swelling growth and no metastatic spread, so surgery can completely remove the tumor, and there is no need for chemotherapy and other medical treatment after surgery, so the prognosis is good and rarely recurrence. Now, the research on the treatment of some malignant tumors has made some progress, and some non-specific tumor growth inhibitors have been listed abroad, which can appropriately prolong the survival time of some patients with malignant skeletal tumors, but they should be used under the guidance of orthopedic or oncologists. Quality nursing measures and good living environment can also slow down the growth, metastasis and spread of malignant tumors. Once skeletal tumors are detected, they should be treated as soon as possible, and the earlier the treatment time, the better the effect.